טוען...
Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis
BACKGROUND: Higher doses of erythropoiesis-stimulating agents (ESA) have been associated with an increased risk of adverse outcomes in adults with chronic kidney disease (CKD) and end-stage kidney disease (ESRD), but to our knowledge no trials have been performed in children. We examined the associa...
שמור ב:
| הוצא לאור ב: | Pediatr Nephrol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4448694/ https://ncbi.nlm.nih.gov/pubmed/24794833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-014-2820-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|